Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kratom NC is a Wilmington, North Carolina retail business that sells kratom, kava, CBD, and related hemp-derived consumer products through a physical storefront and website. Public business listings describe the company as importing kratom from Indonesia, packaging powder and capsules in-house, and offering multiple kratom strains, extracts, and ancillary wellness products. The business appears to operate as a specialty botanical retail shop rather than a drug-development, biotech, pharma, or healthcare company. It has drawn regulatory scrutiny: in 2019, the U.S. FDA issued a warning letter and consumer alert regarding kratom-containing products marketed by Kratom NC, citing unapproved drug claims and contamination concerns. Based on available evidence, it is best categorized as a commercial retailer in the kratom/CBD space, not a life sciences developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kratom NC.